163 related articles for article (PubMed ID: 28234254)
1. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.
Hollands S; Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Harrington K; Porter T; Snyder P; Ames D; Fowler C; Rainey-Smith SR; Martins RN; Salvado O; Robertson J; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2017; 57(2):411-422. PubMed ID: 28234254
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.
Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith S; Robertson J; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2018; 65(4):1313-1325. PubMed ID: 30149452
[TBL] [Abstract][Full Text] [Related]
3. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
[TBL] [Abstract][Full Text] [Related]
4. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
[TBL] [Abstract][Full Text] [Related]
5. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
[TBL] [Abstract][Full Text] [Related]
6. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
7. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women.
Szoeke C; Goodwill AM; Gorelik A; Dennerstein L; Caeyenberghs K; Simpson S; Hill E; Campbell S
J Alzheimers Dis; 2019; 68(1):105-114. PubMed ID: 30689578
[TBL] [Abstract][Full Text] [Related]
10. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
[TBL] [Abstract][Full Text] [Related]
11. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
[TBL] [Abstract][Full Text] [Related]
12. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.
Perin S; Harrington KD; Lim YY; Ellis K; Ames D; Pietrzak RH; Schembri A; Rainey-Smith S; Salvado O; Laws SM; Martins RN; Villemagne VL; Rowe CC; Masters CL; Maruff P;
J Affect Disord; 2018 Mar; 229():269-274. PubMed ID: 29329059
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
Wang J; Wang M; Ren S; Huang L; He K; Li J; Hua F; Guan Y; Guo Q; Huang Q; Xie F
J Alzheimers Dis; 2023; 94(2):763-775. PubMed ID: 37334590
[TBL] [Abstract][Full Text] [Related]
15. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
[TBL] [Abstract][Full Text] [Related]
16. Visual Memory Deficits in Middle-Aged APOEɛ4 Homozygotes Detected Using Unsupervised Cognitive Assessments.
Lim YY; Pase MP; Buckley RF; Yassi N; Bransby L; Fowler C; Laws SM; Masters CL; Maruff P
J Alzheimers Dis; 2021; 79(4):1563-1573. PubMed ID: 33492293
[TBL] [Abstract][Full Text] [Related]
17. Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults.
Slee MG; Rainey-Smith SR; Villemagne VL; Doecke JD; Sohrabi HR; Taddei K; Ames D; Dore V; Maruff P; Laws SM; Masters CL; Rowe CC; Martins RN; Erickson KI; Brown BM
Alzheimers Dement; 2024 Feb; 20(2):1350-1359. PubMed ID: 37984813
[TBL] [Abstract][Full Text] [Related]
18. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.
Gardener SL; Rainey-Smith SR; Sohrabi HR; Weinborn M; Verdile G; Fernando WMADB; Lim YY; Harrington K; Burnham S; Taddei K; Masters CL; Macaulay SL; Rowe CC; Ames D; Maruff P; Martins RN;
J Alzheimers Dis; 2017; 58(1):193-201. PubMed ID: 28387666
[TBL] [Abstract][Full Text] [Related]
19. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
